Results 271 to 280 of about 116,862 (285)

In Silico Structural Analysis of Human β‐Glucuronidase for Antibody–Drug Conjugates Optimization

open access: yesProteins: Structure, Function, and Bioinformatics, EarlyView.
ABSTRACT Human β‐glucuronidase (HGUSB), a key lysosomal glycosyl hydrolase for the degradation pathway of glycosaminoglycans (GAGs), plays a crucial role in cell proliferation and inflammation, making it a promising target for novel therapeutic strategies including antibody‐drug conjugates (ADCs) with β‐glucuronic linkers.
Giorgia Canini   +5 more
wiley   +1 more source

Investigating the Potential of Curcumin in the Treatment of Nonsmall Cell Lung Cancer: A Systematic Review With Meta‐Analysis, Network Pharmacology, and Mendelian Randomization

open access: yesPhytotherapy Research, EarlyView.
ABSTRACT To evaluate the efficacy and explore the potential mechanism of curcumin for the treatment and prevention of NSCLC. We searched six databases thoroughly for articles published before December 2024. Stata 15.0 software was applied for systematic review with meta‐analysis.
Yonglu Guo   +3 more
wiley   +1 more source

Facile Decellularization of Stem Cell Spheroids by Integrating Bioactive Nanofibers for Enhanced Wound Healing

open access: yesSmall, EarlyView.
Decellularized stem cell spheroids are limited by inefficient detergent penetration and biomolecule loss. A strategy using polydopamine‐coated nanofibers within hADSC spheroids enables efficient DNA removal while preserving extracellular matrix proteins.
Seung Jae Huh   +7 more
wiley   +1 more source

Bridging the Gap: How Organ‐on‐a‐Chip Technology Facilitates the Battle against Glioma

open access: yesSmall Science, EarlyView.
This review critically evaluates current state‐of‐the‐art in vitro glioma models especially glioma‐on‐a‐chip models based on readout capability, performance, and physiological relevance. It summarizes the key parameters and proposes a practical framework to guide researchers in selecting the most suitable preclinical models for glioma studies.
Su Liu   +5 more
wiley   +1 more source

Immunomodulatory Biomaterials for Bone and Soft Tissue Chronic Inflammation Diseases

open access: yesSmall Science, EarlyView.
This review analyzes immunomodulatory biomaterial strategies for treating chronic inflammatory disorders in bone and soft tissues. It explores emerging mechanisms for resolving inflammation while promoting tissue regeneration, offering insights for developing targeted immunotherapeutic approaches that bridge material science with immunology for ...
Yiming Li   +7 more
wiley   +1 more source

The Challenges of Vascular Implants: Regulatory Strategies and Biological Responses

open access: yesSmall Science, EarlyView.
Implantable vascular devices are revolutionizing the management of cardiovascular diseases, such as heart failure, by enabling real‐time monitoring and individualized therapy. However, their potential is challenged by regulatory constraints and biological barriers, as device implantation into a vessel can trigger inflammation, thrombosis, and long‐term
Serena Babboni   +5 more
wiley   +1 more source

HA Self‐Assembled Dual‐Drug‐Loaded Nanoparticles: Integrating Multitargeted Tumor Therapy and Immune Microenvironment Remodeling via Phototherapy and Apoptosis

open access: yesSmall Structures, EarlyView.
The novel anti‐tumor nanoparticle ICG‐HA‐ADH‐CBA‐TATKLA (IHTK) can simultaneously release the fusion peptide TAT‐KLA (TK) and indocyanine green (ICG) in the tumor microenvironment. Specifically, TK can directly activate the mitochondrial apoptosis pathway to induce tumor cell apoptosis; while ICG, under near‐infrared irradiation, enables phototherapy ...
Lixuan Zang   +9 more
wiley   +1 more source

Unravelling the molecular network structure of biohybrid hydrogels. [PDF]

open access: yesMater Today Bio
Sievers-Liebschner J   +7 more
europepmc   +1 more source

Potential health benefits of insect bioactive metabolites and consumer attitudes towards edible insects. [PDF]

open access: yesNPJ Sci Food
Ishara J   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy